NFG
TEVA icon

Next Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

Next Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$97K Buy
12,126
+1,526
+14% +$13.8K 0.01% 1184
2021
Q3 		$104K Buy
10,600
+164
+2% +$1.54K 0.01% 1093
2021
Q2 		$103K Sell
10,436
-372
-3% -$3.94K 0.01% 1098
2021
Q1 		$125K Buy
10,808
+3,312
+44% +$38K 0.01% 934
2020
Q4 		$72K Sell
7,496
-7,414
-50% -$71K 0.01% 1080
2020
Q3 		$134K Buy
+14,910
New +$158K 0.01% 758
2020
Q2 		– Sell
-6,824
Closed -$61K – 1768
2020
Q1 		$61K Buy
6,824
+2,969
+77% +$30.4K 0.01% 921
2019
Q4 		$38K Sell
3,855
-546
-12% -$4.88K ﹤0.01% 1303
2019
Q3 		$30K Buy
4,401
+125
+3% +$958 ﹤0.01% 1308
2019
Q2 		$39K Buy
4,276
+3,394
+385% +$40.9K ﹤0.01% 1245
2019
Q1 		$14K Sell
882
-2,764
-76% -$48.7K ﹤0.01% 1045
2018
Q4 		$56K Buy
3,646
+2,479
+212% +$50.8K 0.01% 774
2018
Q3 		$25K Buy
+1,167
New +$27.1K 0.01% 719
2017
Q4 		– Sell
-9,877
Closed -$148K – 1297
2017
Q3 		$148K Sell
9,877
-697
-7% -$15.7K 0.04% 393
2017
Q2 		$351K Buy
10,574
+6,350
+150% +$197K 0.09% 244
2017
Q1 		$133K Sell
4,224
-4,297
-50% -$147K 0.04% 413
2016
Q4 		$309K Buy
8,521
+1,383
+19% +$55.2K 0.05% 347
2016
Q3 		$328K Buy
7,138
+2,401
+51% +$125K 0.06% 332
2016
Q2 		$237K Buy
4,737
+575
+14% +$30.6K 0.08% 266
2016
Q1 		$222K Buy
4,162
+1,175
+39% +$68.9K 0.08% 266
2015
Q4 		$196K Sell
2,987
-475
-14% -$29.4K 0.07% 284
2015
Q3 		$195K Hold
3,462
– – 0.07% 288
2015
Q2 		$204K Sell
3,462
-200
-5% -$12.3K 0.07% 294
2015
Q1 		$228K Buy
3,662
+150
+4% +$8.72K 0.07% 291
2014
Q4 		$202K Sell
3,512
-2,328
-40% -$130K 0.07% 305
2014
Q3 		$314K Buy
5,840
+5,754
+6,691% +$305K 0.06% 335
2014
Q2 		$4K Buy
+86
New +$4.4K ﹤0.01% 988

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Next Financial Group's TEVA Position: Q4 2021 in Review

Next Financial Group increased its Teva Pharmaceuticals (TEVA) stake by 14% in Q4 2021, buying an estimated $13.8K and bringing the position to 12,126 shares worth $97K. The position accounts for 0.01% of the portfolio, ranked #1184.

Next Financial Group first reported a position in TEVA in Q2 2014 and has held it in 27 quarters since. The position peaked at $351K in Q2 2017. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

  • Next Financial Group held 12,126 shares of Teva Pharmaceuticals worth $97K as of Q4 2021.
  • Next Financial Group bought 1,526 Teva Pharmaceuticals shares in Q4 2021, an estimated $13.8K.
  • Teva Pharmaceuticals made up 0.01% of Next Financial Group's portfolio in Q4 2021, its #1184 holding.
  • Next Financial Group first reported a position in Teva Pharmaceuticals in Q2 2014 and has held it in 27 quarters since.
  • Next Financial Group's Teva Pharmaceuticals position peaked at $351K in Q2 2017.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.